Project name: Project category: Kind of research: Country: Principle investigator:

Personalised Engineered Cell Therapies for Cystic Fibrosis

New Therapies
Basic research United Kingdom Prof. Stephen Hart
Status: Ongoing

determine the most effective approaches to CRISPR-mediated gene editing therapy for cystic fibrosis

UK CF Trust Grant Code: Strategic Research Centre 006

City: London (England)
Project amount (€): 819.206,28

Contact information

  • Hilde De Keyser
  • 0032 - (0)2 61 32 716
  • Driebruggenstraat 124, 1160 Brussel
  • Chamber of Commerce number: 0640.670.746

Subscribe to newsletter